VDO QuantoBio
VDO QuantoBio is a World Leading Flow Cytometry Solution Manufacturer in flow cytometer and FC reagents
VDO QuantoBio is a World Leading Flow Cytometry Solution Manufacturer in flow cytometer and FC reagents
Beijing QuantoBio Biotechnology Co.,Ltd. is a leading company in the biotechnology and health care industries, specializing in flow cytometry solutions. The company offers a range of products including flow cytometers, flow antibodies, and kits for research and diagnostic applications. Its subsidiary, QuantoBio, focuses on developing high-quality antibodies and reagents for flow cytometry with over 30 years of experience in monoclonal antibody production.
With ISO 9001 and ISO13485:2016 certification, the company guarantees the long-term delivery of products with consistent quality. The last recorded investment in September 2017 amounted to CNY45.00M, through a Post-IPO Equity investment, with Jiahao Group and Northeast Securities as the investors.
QuantoBio is committed to providing customers with multiple high-quality and affordable choices, along with superior customer service and technical support. Founded in 2009, the company's dedication to innovation and quality positions it as a prominent player in the field of flow cytometry solutions.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | CNY45.00M | 2 | Jiahao Group, Northeast Securities | 19 Sep 2017 |
| Series B | CNY10.00M | 1 |
|
29 Jul 2014 |
| Venture Round | CNY15.00M | 1 | Shanghai Chenshan Investment Management | 08 Feb 2014 |
| Series A | CNY14.50M | 1 |
|
31 Dec 2013 |
| Angel Round | CNY4.50M | 1 | Beijing Kanghua Investment | 19 Aug 2013 |
No recent news or press coverage available for VDO QuantoBio.
We care about your data, and we'd love to use cookies make your experience better.
